Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients

✍ Scribed by Yusuf Sezen; Memduh Bas; Halil Altıparmak; Ali Yildiz; Hakan Buyukhatipoglu; Omer Faruk Dag; Zekeriya Kaya; Nurten Aksoy

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 117 KB
• Volume: 24
• Category: Article
• ISSN: 0887-8013
• DOI: 10.1002/jcla.20388

✦ Synopsis

Abstract

Idiopathic and ischemic dilated cardiomyopathies (DCM) are the most common types of DCM, and both exhibit the same histopathological feature of fibrosis. Prolidase is an enzyme that serves a rate‐limiting function in collagen turnover. Several studies have shown increased prolidase activity in fibrosis, though controversy persists. In this study, we measured prolidase enzyme activity in patients with idiopathic or ischemic DCM and in healthy controls, making this, to our knowledge, the first study to do so. What we found is that serumprolidase activity was significantly lower in both DCM groups relative to healthy volunteers and lower in ischemic DCM than idiopathic. These intriguing results could be attributed either to decreased collagen turnover in the heart tissues in which DCM develops, a result of diminished functional heart tissue, or to decreased physical activity levels among DCM patients stemming from their heart failure. Either way, further studies are needed to verify and clarify our results. J. Clin. Lab. Anal. 24:213–218, 2010. © 2010 Wiley‐Liss, Inc.